Erratum: A randomized controlled trial comparing efficacy and safety of insulin glargine 300 units/mL versus 100 units/mL in older people with type 2 diabetes: Results from the SENIOR study. (Diabetes care (2018) 41(1672-1680)DOI: 10.2337/dc09-19er08)

Robert Ritzel, Stewart B. Harris, Helen Baron, Hermes Florez, Ronan Roussel, Melanie Espinasse, Isabel Muehlen-Bartmer, Nianxian Zhang, Monica Bertolini, Claire Brulle-Wohlhueter, Medha Munshi, Geremia B. Bolli

Research output: Contribution to journal › Comment/debate › peer-review

Fingerprint

Dive into the research topics of 'Erratum: A randomized controlled trial comparing efficacy and safety of insulin glargine 300 units/mL versus 100 units/mL in older people with type 2 diabetes: Results from the SENIOR study. (Diabetes care (2018) 41(1672-1680)DOI: 10.2337/dc09-19er08)'. Together they form a unique fingerprint.

Medicine & Life Sciences